Floatz logo

Gallium-68 Labelled Fap-2286

Solid Tumors, Adult

Thomas HoperadiopharmaceuticalPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

35 Active assets in the Solid Tumors, Adult cohort.

Asset / SponsorPhaseRating
Ribociclib
Eli Lilly and Company
Phase 1/2CC
TAMOXIFEN
Eli Lilly and Company
Phase 1/2CC
Letrozole
Eli Lilly and Company
Phase 1/2CC
Zoladex
Eli Lilly and Company
Phase 1/2CC
Cyclophosphamide
Tango Therapeutics, Inc.
Phase 1/2CC

View all 38 →

Same molecule, other indications

Gallium-68 Labelled Fap-2286 is also rated in:

breast cancerDormant
CCC
Indicative ·
53 / 100
View asset →
Myocardial FibrosisDormant
CC
Indicative ·
47 / 100
View asset →
fibrotic liver diseaseDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →